Back
AbbVie Quote, Financials, Valuation and Earnings
Sponsored
ABBV
Sponsored
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Buy
60
ABBV
AbbVie
Last Price:
162.52
Seasonality Move:
-0.31%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surgeAbbVie Price Quote
$162.52
-0.21 (-0.13%)
(Updated: May 7, 2024 at 6:55 PM ET)
AbbVie Key Stats
Buy
60
AbbVie (ABBV)
is a Buy
Day range:
$161.00 - $164.63
52-week range:
$130.96 - $182.89
Dividend yield:
3.72%
P/E ratio:
59.83
P/S ratio:
5.30
P/B ratio:
35.89%
Volume:
5.7M
Avg. volume:
5.5M
1-year change:
9.93%
Market cap:
$287.4B
Revenue:
$54.3B
EPS:
$3.37
How Much Does AbbVie Make?
Is AbbVie Growing As A Company?
AbbVie Stock Price Performance
What Is AbbVie 52-Week High & Low?
AbbVie Price To Free Cash Flow
-
Is AbbVie Stock Overvalued?
AbbVie is trading at a price to free cash flow ratio of 13.18 -
Is AbbVie Stock Undervalued?
AbbVie EV to Free Cash Flow ratio is 15.68 -
What Is AbbVie’s Price Earnings Growth Ratio?
ABBV PEG ratio is 0.00 -
Is AbbVie Trading At A Premium To Earnings?
AbbVie EV to EBIT ratio is 34.82
Is It Risky To Buy AbbVie?
Is AbbVie Cash Flow Positive?
AbbVie Return On Invested Capital
AbbVie Earnings Date & Stock Price
-
What Is AbbVie's Stock Price Today?
A single share of ABBV can be purchased today for 162.73 -
What Is AbbVie’s Stock Symbol?
AbbVie trades on the S&P500 under the ticker symbol: ABBV -
When Is AbbVie’s Next Earnings Date?
The next quarterly earnings date for AbbVie is scheduled on July 26, 2024 -
When Is ABBV's next ex-dividend date?
AbbVie's next ex-dividend date is April 12, 2024 -
How To Buy AbbVie Stock?
You can buy AbbVie shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
AbbVie Competitors
AbbVie Dividend Yield
AbbVie Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 492.31% | 2.18% |
Revenue: | 0.7% | 3.14% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 12 |
Sell Recommendations: | 0 |
Price Target: | 182.31 |
Upside from Last Price: | 12.03% |